Vice President Clinical Operations
-
sector
US Recruitment
-
location
Somerville
-
type
Permanent
Vice President, Clinical Operations – Immunology / Biologics
Location: United States | Remote
Employment: Full-Time | Permanent
Level: Vice President
Therapeutic Area: Immunology / Inflammation / Immune-Mediated Diseases
Are you an experienced Clinical Operations leader with a strong background in early-stage clinical development and global trial execution? This is an exciting opportunity to join an innovative, rapidly growing biotechnology company leveraging AI-driven drug discovery and next-generation biologics to develop breakthrough therapies for patients with complex immune-mediated diseases.
We are seeking a strategic, hands-on VP of Clinical Operations to lead and build the global Clinical Operations function, overseeing the operational delivery of programmes from candidate selection and IND/CTA-enabling activities through First-in-Human (FIH), Phase 1, Phase 1b Proof-of-Mechanism (PoM) and Phase 2a Proof-of-Concept (PoC) studies. The successful candidate will thrive in a fast-paced biotech environment, combining strong scientific and operational judgement with the ability to lead global clinical programmes, build high-performing teams and drive complex development activities across multiple geographies.
Key Responsibilities:
-
Define and lead global Clinical Operations strategies across early-stage immunology and inflammation programmes, from preclinical development through Phase 2a Proof-of-Concept and into later-stage development.
-
Lead the operational planning and execution of global FIH, Phase 1, Phase 1b PoM and Phase 2a PoC clinical trials.
-
Build, develop and lead a high-performing global Clinical Operations function, establishing clear accountabilities, governance structures and operational frameworks.
-
Oversee the transition of preclinical candidates into clinical development, coordinating IND/CTA readiness, FIH initiation, critical milestones and operational budgets.
-
Partner with Clinical Development, Translational Science, Regulatory Affairs, CMC, DMPK, Toxicology, Safety and Clinical Pharmacology to ensure integrated programme execution.
-
Oversee clinical trial design and operational feasibility, including site selection, patient recruitment, dose cohorts, study endpoints and trial timelines.
-
Lead CRO and external vendor selection, management and oversight, ensuring high-quality trial delivery, compliance and operational efficiency.
-
Oversee site activation, investigator relationships, patient recruitment, clinical monitoring, safety oversight and clinical data quality.
-
Drive innovative clinical trial approaches, including adaptive designs, basket/platform studies, decentralised trial elements and digital endpoints where appropriate.
-
Develop and manage integrated operational plans, budgets, resource allocations, dependencies and programme milestones.
-
Identify and mitigate scientific, regulatory, technical and operational risks, ensuring patient safety, quality and compliance throughout clinical development.
-
Support IND/CTA submissions and global regulatory activities, including operational readiness across the US, China and Europe.
-
Present clinical operations strategies, programme updates, investment recommendations and development risks to executive leadership and governance committees.
-
Support business development, strategic partnerships, licensing activities and external due diligence where required.
Candidate Requirements:
-
PhD, MD, PharmD or equivalent advanced scientific/medical qualification – essential.
-
7–10+ years of biotechnology or pharmaceutical clinical operations experience, with significant leadership responsibility.
-
Proven experience leading global early-phase clinical trials, particularly First-in-Human, Phase 1, Phase 1b and Phase 2a Proof-of-Concept programmes.
-
Strong understanding of end-to-end drug development, including preclinical development, translational medicine, regulatory affairs, CMC, DMPK and clinical pharmacology.
-
Experience leading the transition of drug candidates from preclinical development into clinical trials, including IND/CTA-enabling activities.
-
Demonstrated experience managing global CROs, external vendors, clinical trial budgets, timelines and operational deliverables.
-
Strong understanding of FDA, EMA and international regulatory requirements, including clinical trial submissions and ICH-GCP.
-
Experience overseeing clinical trial safety, quality management, patient recruitment, site activation and clinical data quality.
-
Background in immunology, inflammation or immune-mediated diseases, including dermatology, rheumatology, gastroenterology or respiratory indications, is highly desirable.
-
Experience with biologics, monoclonal antibodies, multispecific antibodies or other innovative therapeutic modalities is advantageous.
-
Proven ability to lead multidisciplinary teams and influence stakeholders across Clinical Development, Regulatory, CMC, Translational Science and Research.
-
Experience with global development programmes involving the US, China and Europe is desirable.
-
Strong strategic leadership, communication, stakeholder management and problem-solving skills.
-
Comfortable operating within a fast-paced, entrepreneurial biotechnology environment with evolving priorities.
What's on Offer?
-
Senior executive leadership opportunity within an innovative, rapidly growing biotechnology company.
-
Opportunity to build and lead the global Clinical Operations function from an exciting stage of company growth.
-
Exposure to cutting-edge AI-enabled drug discovery and next-generation biologics development.
-
Significant influence over global clinical development strategy and operational delivery across an expanding immunology pipeline.
-
Opportunity to oversee programmes from preclinical development and IND/CTA submissions through FIH and clinical Proof-of-Concept.
-
International exposure, working across global development teams, regulatory environments and strategic pharmaceutical partnerships.
-
Direct collaboration with the Chief Medical Officer, senior scientific leadership and executive stakeholders.
-
Science-driven, entrepreneurial environment offering substantial strategic responsibility and the opportunity to shape the company's clinical development capabilities.